glyoxal has been researched along with MS (Multiple Sclerosis) in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boada, J; Brieva, L; Cacabelos, D; Cassanyé, A; González, C; Gonzalo, H; Hernández, L; Jové, M; Lanau-Angulo, L; Pamplona, R; Peralta, S; Portero-Otin, M; Serrano, JC; Tatzber, F | 1 |
1 other study(ies) available for glyoxal and MS (Multiple Sclerosis)
Article | Year |
---|---|
Lipidome analysis in multiple sclerosis reveals protein lipoxidative damage as a potential pathogenic mechanism.
Topics: Adult; Autoantibodies; Cell Line, Transformed; Chromatography, High Pressure Liquid; Fatty Acids; Female; Glyoxal; Humans; Lipid Peroxidation; Lipids; Lipoproteins, LDL; Male; Malondialdehyde; Mass Spectrometry; Metabolic Networks and Pathways; Middle Aged; Mucoproteins; Multiple Sclerosis; PPAR gamma; Protein Carbonylation; Pyruvaldehyde | 2012 |